• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SOFRADIM PRODUCTION SAS MESH SOFRADIM - PARIETEX¿ OPTIMIZED COMPOSITE MESH; MESH, SURGICAL, POLYMERIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SOFRADIM PRODUCTION SAS MESH SOFRADIM - PARIETEX¿ OPTIMIZED COMPOSITE MESH; MESH, SURGICAL, POLYMERIC Back to Search Results
Model Number PCO2015X
Device Problems Mechanics Altered (2984); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Wound Dehiscence (1154); Abdominal Pain (1685); Abscess (1690); Adhesion(s) (1695); Purulent Discharge (1812); Emotional Changes (1831); Fistula (1862); Failure of Implant (1924); Unspecified Infection (1930); Inflammation (1932); Nausea (1970); Necrosis (1971); Pain (1994); Vomiting (2144); Cramp(s) (2193); Hernia (2240); Injury (2348); Impaired Healing (2378); Obstruction/Occlusion (2422); No Code Available (3191); Constipation (3274); Cramp(s) /Muscle Spasm(s) (4521); Unspecified Tissue Injury (4559); Swelling/ Edema (4577); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
The patient's attorney alleged a deficiency against the device resulting in an unspecified adverse outcome.Product was used for therapeutic treatment.The patient underwent a ventral hernia repair with mesh.He had revision surgery but the time line was not given on the source documentation.The patient experienced infection, hernia recurrence.A physician has recommended surgical intervention.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
The patient's attorney alleged a deficiency against the device.The product was used for laparoscopic therapeutic treatment of a ventral hernia.It was reported that after implant, the patient experienced adhesions, infection, abscess, wound dehiscence, fascial necrosis, open wound, obstruction, mildly diffuse prominence, abdominal pain, vomiting bile, no bowel movement for two weeks, cramping, pain, nausea, fistula, necrosis, purulent fluid, hernia recurrence, mental pain, physical pain, suffering, disability, impairment, loss of enjoyment of life, defective device, and failure of mesh.Post-operative patient treatment included revision surgery, wound vac placement, recurrence repair, sigmoid colectomy, component separation, abdominal wound washout, apply abdominal wall retention suture, debridement of abscess, and extensive lysis of adhesions.
 
Manufacturer Narrative
This information was received as a part of an extensive mesh litigation submission to medtronic.The fda was notified of this large complaint receipt.Due to the volume of complaint information received by medtronic, this resulted in a report beyond the 30 day target.If information is provided in the future, a supplemental report will be issued.
 
Event Description
The patient's attorney alleged a deficiency against the device.The product was used for therapeutic treatment of a ventral hernia.It was reported that after implant, the patient experienced adhesions, infection, abscess, wound dehiscence, fascial necrosis, open wound, hernia recurrence.Post-operative patient treatment included revision surgery, wound vac placement, recurrence repair and extensive lysis of adhesions.
 
Event Description
The patient's attorney alleged a deficiency against the device.The product was used for laparoscopic therapeutic treatment of a ventral hernia.It was reported that after implant, the patient experienced adhesions, infection, abscess, wound dehiscence, fascial necrosis, open wound, obstruction, mildly diffuse prominence, abdominal pain, vomiting bile, no bowel movement for two weeks, cramping, pain, nausea, fistula, necrosis, purulent fluid, and hernia recurrence.Post-operative patient treatment included revision surgery, wound vac placement, recurrence repair, sigmoid colectomy, component separation, abdominal wound washout, apply abdominal wall retention suture, debridement of abscess, and extensive lysis of adhesions.
 
Manufacturer Narrative
This information was received as a part of an extensive mesh litigation submission to medtronic.The fda was notified of this large complaint receipt.Due to the volume of complaint information received by medtronic, this resulted in a report beyond the 30 day target.Additional information: a1, a3, a5b, b5, b6, b7, e3, e4(email), g4, h6.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event Description
The patient's attorney alleged a deficiency against the device.The product was used for laparoscopic therapeutic treatment of a ventral hernia.It was reported that after implant, the patient experienced edematous colon mucosa, inflammation, fascial dehiscence, adhesions, infection, abscess, wound dehiscence, fascial necrosis, open wound, obstruction, mildly diffuse prominence, abdominal pain, vomiting bile, no bowel movement for two weeks, cramping, pain, nausea, fistula, necrosis, purulent fluid, hernia recurrence, mental pain, physical pain, suffering, disability, impairment, loss of enjoyment of life, defective device, and failure of mesh.Post-operative patient treatment included ct scan, barium enema, exploratory laparotomy, revision surgery, wound vac placement, recurrence repair, sigmoid colectomy, end colostomy, component separation, abdominal wound washout, apply abdominal wall retention suture, use of blake drain, debridement of abscess, removal of mesh, hernia repair with new mesh, and extensive lysis of adhesions.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MESH SOFRADIM - PARIETEX¿ OPTIMIZED COMPOSITE MESH
Type of Device
MESH, SURGICAL, POLYMERIC
Manufacturer (Section D)
SOFRADIM PRODUCTION SAS
116 avenue du formans
trevoux 01600
FR  01600
Manufacturer (Section G)
SOFRADIM PRODUCTION SAS
116 avenue du formans
trevoux 01600
FR   01600
Manufacturer Contact
justin ellis
5920 longbow drive
8200 coral sea st ne
mounds view,mn, CO 55112
7635265677
MDR Report Key7449737
MDR Text Key106138184
Report Number9615742-2018-00970
Device Sequence Number1
Product Code FTL
UDI-Device Identifier10884521179769
UDI-Public10884521179769
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K110815
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 07/15/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/31/2018
Device Model NumberPCO2015X
Device Catalogue NumberPCO2015X
Device Lot NumberPNK0083X
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 03/23/2018
Initial Date FDA Received04/22/2018
Supplement Dates Manufacturer Received06/12/2019
06/12/2019
09/22/2021
07/10/2024
Supplement Dates FDA Received01/09/2020
02/18/2020
10/12/2021
07/15/2024
Date Device Manufactured11/14/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Disability; Required Intervention; Other;
Patient Age53 YR
Patient SexFemale
Patient Weight102 KG
Patient RaceBlack Or African American, White
-
-